ACH
LEGN icon

ArrowMark Colorado Holdings’s Legend Biotech LEGN Stock Holding History

ArrowMark Colorado Holdings’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Sell
362,781
-364,363
-50% -$9.83M 0.44% 82
2026
Q1 		$13.2M Buy
727,144
+5,354
+0.7% +$102K 0.35% 86
2025
Q4 		$15.7M Sell
721,790
-216,888
-23% -$6.21M 0.35% 85
2025
Q3 		$30.6M Sell
938,678
-44,832
-5% -$1.66M 0.57% 56
2025
Q2 		$34.9M Sell
983,510
-147,595
-13% -$4.78M 0.63% 55
2025
Q1 		$38.4M Sell
1,131,105
-46,435
-4% -$1.67M 0.62% 55
2024
Q4 		$38.3M Buy
1,177,540
+223,975
+23% +$9.28M 0.52% 61
2024
Q3 		$46.5M Sell
953,565
-109,169
-10% -$5.82M 0.6% 54
2024
Q2 		$47.1M Buy
1,062,734
+15,995
+2% +$738K 0.56% 53
2024
Q1 		$58.7M Sell
1,046,739
-17,803
-2% -$1.07M 0.66% 44
2023
Q4 		$64.1M Sell
1,064,542
-9,729
-0.9% -$617K 0.71% 48
2023
Q3 		$72.2M Hold
1,074,271
– – 0.88% 35
2023
Q2 		$74.2M Buy
1,074,271
+2,777
+0.3% +$181K 0.81% 40
2023
Q1 		$51.7M Buy
1,071,494
+36,061
+3% +$1.76M 0.59% 51
2022
Q4 		$51.7M Buy
1,035,433
+18,753
+2% +$909K 0.62% 51
2022
Q3 		$41.5M Buy
1,016,680
+811,110
+395% +$38.1M 0.51% 58
2022
Q2 		$11.3M Buy
205,570
+39,589
+24% +$1.67M 0.13% 146
2022
Q1 		$6.03M Buy
165,981
+78,160
+89% +$3.09M 0.05% 232
2021
Q4 		$4.09M Hold
87,821
– – 0.03% 249
2021
Q3 		$4.44M Hold
87,821
– – 0.03% 256
2021
Q2 		$3.6M Hold
87,821
– – 0.03% 256
2021
Q1 		$2.55M Sell
87,821
-108,035
-55% -$2.95M 0.02% 264
2020
Q4 		$5.51M Buy
195,856
+145,856
+292% +$4.2M 0.04% 225
2020
Q3 		$1.54M Hold
50,000
– – 0.01% 272
2020
Q2 		$2.13M Buy
+50,000
New +$1.95M 0.02% 229

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

ArrowMark Colorado Holdings's LEGN Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its Legend Biotech (LEGN) stake by 50% in Q2 2026, selling an estimated $9.83M and leaving 362,781 shares worth $10.5M. The position accounts for 0.44% of the portfolio, ranked #82.

ArrowMark Colorado Holdings first reported a position in LEGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $74.2M in Q2 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • ArrowMark Colorado Holdings held 362,781 shares of Legend Biotech worth $10.5M as of Q2 2026.
  • ArrowMark Colorado Holdings sold 364,363 Legend Biotech shares in Q2 2026, an estimated $9.83M.
  • Legend Biotech made up 0.44% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #82 holding.
  • ArrowMark Colorado Holdings first reported a position in Legend Biotech in Q2 2020 and has held it in 25 quarters since.
  • ArrowMark Colorado Holdings's Legend Biotech position peaked at $74.2M in Q2 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.